New cancer drug trial seeks to control advanced tumors
Disease control
Recruiting now
This study is testing a new drug called NP-G2-044 to see if it is safe and can help control advanced cancers that have spread. It will be given to about 140 adults, both by itself and combined with a common immunotherapy. The main goals are to find the right dose and check for ea…
Phase: PHASE1, PHASE2 • Sponsor: Novita Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC